In accordance with the guidelines outlined in the National Medical Products Administration (NMPA) Technical Guideline for Bioequivalence Studies of Generic Chemical Drugs with Pharmacokinetic Parameters as the Endpoints, and considering the characteristics of the drug used in this study, the overall design was a single-center, open-label, randomized, two-formulation, two-period, two-way crossover, fasting pharmacokinetic study
In addition, keep tabs on any new symptoms after starting a supplement, such as muscle pain, dark urine, jaundice, or severe gastrointestinal symptoms, all of which can be signs of liver or kidney dysfunction
NAD+ is involved in over 500 enzymatic reactions in the body
Hypermethioninemia provokes oxidative damage and histological changes in liver of rats